Pacific Shuanglin Bio-pharmacy Co., Ltd. (000403.SZ) Stock
—
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Ownership
About Pacific Shuanglin Bio-pharmacy Co., Ltd.
—
Pacific Shuanglin Bio-pharmacy Co., Ltd. is led by CEO Xiankui Rong, employs 2,755 people, headquartered in Taiyuan, CN, publicly traded since 2013.
Pacific Shuanglin Bio-pharmacy Co., Ltd. (000403.SZ) stock trades at $9.50 with a market capitalization of $9.56B. The stock is valued at a price-to-earnings (P/E) ratio of 34.69, price-to-book of 1.17, price-to-sales of 3.86. Over the past 52 weeks the stock has ranged between $8.54 and $16.42, and currently trades 42.1% below its 52-week high. It pays a dividend yielding 4.15%.
On profitability, Pacific Shuanglin Bio-pharmacy Co., Ltd. generates a return on equity (ROE) of 3.37%, an operating margin of 12.95%, a net profit margin of 10.82%.
Official website: www.slbiop.com
Pacific Shuanglin Bio-pharmacy Co., Ltd. (000403.SZ) — frequently asked questions
What is Pacific Shuanglin Bio-pharmacy Co., Ltd. (000403.SZ) stock price today?
Pacific Shuanglin Bio-pharmacy Co., Ltd. (000403.SZ) is currently trading at $9.50, down 4.14% today.
What is 000403.SZ P/E ratio?
Pacific Shuanglin Bio-pharmacy Co., Ltd.'s P/E ratio is 34.69. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.
What is 000403.SZ return on equity (ROE)?
Pacific Shuanglin Bio-pharmacy Co., Ltd.'s return on equity (ROE) is 3.37%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.
What is Pacific Shuanglin Bio-pharmacy Co., Ltd.'s market cap?
Pacific Shuanglin Bio-pharmacy Co., Ltd. has a market capitalization of $9.56B.
Does 000403.SZ pay a dividend?
Yes. Pacific Shuanglin Bio-pharmacy Co., Ltd. currently yields 4.15%. Yield moves with the share price, so it changes daily even when the payment does not.
How much debt does 000403.SZ carry?
Pacific Shuanglin Bio-pharmacy Co., Ltd. has a debt-to-equity ratio of 0.15. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is 000403.SZ's profit margin?
Pacific Shuanglin Bio-pharmacy Co., Ltd. reports a net profit margin of 10.82% — the share of revenue left after every cost, including tax and interest.
What sector is 000403.SZ in?
Pacific Shuanglin Bio-pharmacy Co., Ltd. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is 000403.SZ listed on?
Pacific Shuanglin Bio-pharmacy Co., Ltd. trades on SHZ under the ticker 000403.SZ.
What is 000403.SZ's 52-week range?
Over the last year Pacific Shuanglin Bio-pharmacy Co., Ltd. has traded between $8.54 and $16.42.
Related — Stocks
Popular Stocks
Screens 000403.SZ currently matches
On the figures above, Pacific Shuanglin Bio-pharmacy Co., Ltd. passes the filters for 12 of our ready-made screens, among them High Dividend Stocks, Dividend Stocks, Dividend Stocks Under $10. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.